Related Experiment Videos
[Semi-invasive pulmonary aspergillosis. Apropos of a case]
Abstract:
A 43-year-old man was admitted to hospital for excavated pneumopathy of the upper part of the right lung, revealed by signs of respiratory infection evolving for a few weeks and involving a 10-kg weight loss. The radiological and clinical evolution and the demonstration of Aspergillus fumigatus allowed establishing a diagnosis of semi-invasive aspergillosis. The treatment, associating amphotericin B and 5-fluorocytosine, replaced by itraconazole 15 days later, soon produced clinical healing and radiological improvement. Since serology remained positive, surgery was performed to remove the residual lesions after a 7-month course of itraconazole. Within the scope of this case, the diagnostic criteria of this form of pulmonary aspergillosis are discussed, as well as the merits and limitations of itraconazole.
Insights
This case study details a semi-invasive pulmonary aspergillosis diagnosis in a patient with significant weight loss. Treatment involved antifungals and surgery, highlighting diagnostic criteria and itraconazole
Area of Science:
- Pulmonology
- Infectious Diseases
- Mycology
Background:
- Semi-invasive pulmonary aspergillosis is a serious fungal infection.
- Early diagnosis and treatment are crucial for patient outcomes.
Observation:
- A 43-year-old male presented with excavated pneumopathy and respiratory infection symptoms.
- Radiological findings and Aspergillus fumigatus identification confirmed the diagnosis.
Findings:
- Initial treatment with amphotericin B and 5-fluorocytosine, followed by itraconazole, led to clinical and radiological improvement.
- Persistent positive serology necessitated surgical removal of residual lesions after 7 months of itraconazole therapy.
Implications:
- This case underscores the importance of diagnostic criteria for semi-invasive pulmonary aspergillosis.
- It also evaluates the efficacy and limitations of itraconazole in treating this condition.